W Förster
- Biochemistry top 2%
- Eicosanoids and Hypertension Pharmacology 37
- Nutrition and Dietetics top 5%
- Fatty Acid Research and Health 33
- Pharmacology top 5%
- Inflammatory mediators and NSAID effects 29
-
- Cardiac electrophysiology and arrhythmias 14
- Ophthalmology top 5%
-
- Diet and metabolism studies 17
-
- Receptor Mechanisms and Signaling 13
-
- Diet, Metabolism, and Disease 12
-
- Corneal surgery and disorders 12
- Journals
- Prostaglandins (9 papers)Cellular and Molecular Life Sciences (7 papers)British Journal of Pharmacology (6 papers)
- Partner nations
- GermanySouth KoreaUnited States
In The Last Decade
W Förster
185 papers receiving 1.4k citations
Peers
Comparison fields: 5 of 117
- Biochemistry 285
- Nutrition and Dietetics 323
- Pharmacology 285
- Cardiology and Cardiovascular Medicine 322
- Ophthalmology 128
Countries citing papers authored by W Förster
This map shows the geographic impact of W Förster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W Förster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W Förster more than expected).
Fields of papers citing papers by W Förster
This network shows the impact of papers produced by W Förster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W Förster. The network helps show where W Förster may publish in the future.
Co-authorship network
The 25 scholars most cited alongside W Förster, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 10 | |
| 2 | 2002 | 25 | |
| 3 | 1997 | 42 | |
| 4 | 1996 | 0 | |
| 5 | 1995 | 5 | |
| 6 | 1993 | 6 | |
| 7 | 1993 | 13 | |
| 8 | 1993 | 14 | |
| 9 | 1992 | 2 | |
| 10 | 1991 | 2 | |
| 11 | 1991 | 12 | |
| 12 | 1990 | 1 | |
| 13 | Inhibition of lipoxygenase (LOX) or of cyclooxygenase (COX) improves survival of rats in endotoxin shock. | 1988 | 4 |
| 14 | 1988 | 3 | |
| 15 | [Arachidonic acid metabolites and shock]. | 1985 | 1 |
| 16 | The possible biological importance of lipoxygenase pathway in aorta endothelial cells. | 1984 | 1 |
| 17 | SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation. | 1982 | 12 |
| 18 | [Specific differences between the adrenergic beta receptors of the heart and coronary vessels]. | 1972 | 1 |
| 19 | 1971 | 7 | |
| 20 | Palestinian Judaism in New Testament times | 1964 | 4 |
About W Förster
W Förster is a scholar working on Biochemistry, Nutrition and Dietetics and Pharmacology, having authored 198 papers that have together received 1.5k indexed citations. Recurring topics across this work include Eicosanoids and Hypertension Pharmacology (37 papers), Fatty Acid Research and Health (33 papers), Inflammatory mediators and NSAID effects (29 papers), Diet and metabolism studies (17 papers), Cardiac electrophysiology and arrhythmias (14 papers), Receptor Mechanisms and Signaling (13 papers), Diet, Metabolism, and Disease (12 papers) and Corneal surgery and disorders (12 papers). The work is most often cited by research in Biochemistry (285 citations), Nutrition and Dietetics (323 citations) and Pharmacology (285 citations). W Förster has collaborated with scholars based in Germany, South Korea and United States. Frequent co-authors include J. Beitz, P Mentz, Peter Hoffmann, Klaus Pönicke, H. Busse, H.‐J. Mest, Helena Block, P. Hoffman, Hartmut Kühn and W Halle. Their work appears in journals such as Prostaglandins, Cellular and Molecular Life Sciences, British Journal of Pharmacology, Journal of Refractive Surgery and Prostaglandins Leukotrienes and Essential Fatty Acids.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.